Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

Serina Therapeutics (NYSE American: SER), a clinical-stage biotechnology company developing a pipeline of therapies for the treatment of Parkinson’s Disease and other neurological diseases, has announced the closing of its previously announced merger with a wholly-owned subsidiary of AgeX Therapeutics, Inc. The combined company will operate under the name Serina Therapeutics and will trade on the NYSE American market under the ticker symbol “SER” effective with the open of business on Wednesday, March 27, 2024.

Read the full article: Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics //

Source: https://www.globenewswire.com/news-release/2024/03/26/2852790/0/en/Serina-Therapeutics-Announces-Completion-of-Merger-with-AgeX-Therapeutics.html

Leave a Comment

Your email address will not be published.

Scroll to Top